MedTrace Logo

Efficacy of Internet-delivered Trauma-focused CBT for Young People With PTSD

NCT06185244 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-03-13

No results posted yet for this study

Summary

The goal of this clinical trial is to compare therapist-guided internet delivered trauma-focused cognitive behavior therapy (CBT) to an active control condition comprising therapist-guided internet delivered cognitive behavioral therapy containing relaxation techniques and psychoeducation for young people with post-traumatic stress disorder regarding efficacy and cost effectiveness.

Young people with post-traumatic stress disorder will be randomly assigned to receive either 12 weeks of therapist-guided internet delivered trauma-focused cognitive behavior therapy (iTF-CBT) or therapist-guided internet delivered cognitive-behavioral therapy containing relaxation and psychoeducation.

Conditions

Interventions

BEHAVIORAL

Therapist-supported internet-delivered trauma-focused CBT

12 weeks of therapist-supported internet-delivered trauma-focused CBT for both the youth and the care giver.

BEHAVIORAL

12 weeks of therapist-supported internet-delivered psychoeducation and stress management/relaxation for both the youth and the care giver.

12 weeks of therapist-supported internet-delivered psychoeducation and stress management/relaxation for both the youth and the care giver.

Sponsors & Collaborators

  • Child and Adolescent Psychiatry, Stockholm

    collaborator INDUSTRY

  • Save the Children

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Maria Bragesjö, PhD · Karolinska Institutet/Region Stockholm

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2027-01-04
Completion
2028-01-04

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06185244 on ClinicalTrials.gov